DOGZ vs FRPT vs HIMS vs CENT

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -2. 2% for Central Garden & Pet Company (CENT). Central Garden & Pet Company (CENT) offers the better valuation at 15. 1x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate Freshpet, Inc. (FRPT) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Central Garden & Pet Company (CENT) is the cheapest at 15.

1x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Central Garden & Pet Company is actually cheaper at 13. 5x.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -96. 4% for Dogness (International) Corporation (DOGZ). Over 10 years, the gap is even starker: FRPT returned +517. 3% versus DOGZ's -98. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Dogness (International) Corporation (DOGZ) is the lower-risk stock at 0.

42β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 467% more volatile than DOGZ relative to the S&P 500. On balance sheet safety, Dogness (International) Corporation (DOGZ) carries a lower debt/equity ratio of 16% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -2. 2% for Central Garden & Pet Company (CENT). On earnings-per-share growth, the picture is similar: Freshpet, Inc. grew EPS 183. 9% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Freshpet, Inc.

(FRPT) is the more profitable company, earning 12. 6% net margin versus -24. 6% for Dogness (International) Corporation — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FRPT leads at 8. 6% versus -31. 7% for DOGZ. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Central Garden & Pet Company (CENT) trades at 13.

5x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 38. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CENT: 32. 4% to $51. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Dogness (International) Corporation (DOGZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

42)). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DOGZ: -98. 9%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DOGZ (Consumer Cyclical) and FRPT (Consumer Defensive) and HIMS (Healthcare) and CENT (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DOGZ is a small-cap high-growth stock; FRPT is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; CENT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.